Validation of Pre-clinical Nano-Based Analgesics in Cells From Human Dorsal Root Ganglia
NCT ID: NCT04533919
Last Updated: 2025-10-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
8 participants
OBSERVATIONAL
2020-06-16
2027-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Excitability Protocol: Voltage-gated Ion Channels
NCT05368532
In Vitro Studies on Pharmacological Regulation and Genetic Risk Factors of Peripheral Human Nociceptors
NCT00223366
Impact of Peripheral Afferent Input on Central Neuropathic Pain
NCT05646810
Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
NCT00058357
Efficacy of Intrathecal Oxytocin in Patients With Neuropathic Pain
NCT02100956
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To identify translational mechanisms and therapeutics for neuropathic pain, a type of chronic pain that can arise due to injured nerves.
OUTLINE:
Patients' leftover dorsal root ganglia samples are collected during standard of care surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Basic science (dorsal root ganglia collection)
Patients' leftover dorsal root ganglia samples are collected during standard of care surgery.
Biospecimen Collection
Undergo collection of dorsal root ganglia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biospecimen Collection
Undergo collection of dorsal root ganglia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrew J Shepherd
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M D Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Andrew J. Shepherd
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
http://www.mdanderson.org
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2020-05249
Identifier Type: REGISTRY
Identifier Source: secondary_id
2020-0526
Identifier Type: OTHER
Identifier Source: secondary_id
2020-0526
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.